The effects of FGF23 and Klotho on vascular calcification in end stage renal disease patients;<br>

Completed

• Conditions: End stage renal disease; end stage renal failure.; 10038430; 10003216

• Registration Number: NL-OMON47072
• Lead Sponsor: Catharina-ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 70

Inclusion Criteria

Participating in the (pre)dialysis program
Informed consent.

Exclusion Criteria

Age below 18 years.
Withdrawal of consent.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Serum FGF23, Klotho and vitamin D concentrations and their correlation with<br /><br>arterial stiffness as measured by pulse wave velocity. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Correlation between carotid-femoral pulse wave velocity (cfPWV) and<br /><br>WeSTElan-derived PWV (wePWV). </p><br>